Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitomycin C and vindesine associated pulmonary toxicity with variable clinical expression.

D Luedke, T T McLaughlin, C Daughaday

    Cancer
    |February 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Vale Peter Gregor Scott.

    Australian veterinary journal·2025
    Same author

    Frequency of use of the International Classification of Diseases ICD-10 diagnostic categories for mental and behavioural disorders across world regions.

    Epidemiology and psychiatric sciences·2017
    Same author

    SU-E-J-94: Investigating the Use of Deformable Algorithms to Register MR Images Acquired with and Without an Endo-Rectal Coil.

    Medical physics·2017
    Same author

    Editor's notes.

    The Physician and sportsmedicine·2016
    Same author

    Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time?

    Breast cancer research and treatment·2014
    Same author

    Hyperspectral imaging of gel pen inks: an emerging tool in document analysis.

    Science & justice : journal of the Forensic Science Society·2014

    Vindesine chemotherapy can cause lung toxicity in lung cancer patients, presenting as shortness of breath or fatal lung damage. Early recognition and intervention are crucial for managing this adverse effect.

    Area of Science:

    • Pulmonology
    • Medical Oncology
    • Clinical Pharmacology

    Background:

    • Lung cancer patients often receive combination chemotherapy.
    • Mitomycin and vindesine are commonly used agents in lung cancer treatment.

    Observation:

    • A patient on mitomycin and vindesine developed acute shortness of breath post-vindesine.
    • Pulmonary function tests revealed an acute obstructive pattern, responsive to bronchodilators.
    • Arterial blood gas analysis indicated persistent lung damage.

    Findings:

    • A review of 126 patients identified 6 additional cases of possible lung toxicity.
    • The overall incidence of vindesine-related lung toxicity was 5.5%.
    • Clinical presentations ranged from reversible dyspnea to fatal interstitial lung disease.

    Related Experiment Videos

    Implications:

    • Vinca alkaloid chemotherapy, specifically vindesine, poses a risk of significant pulmonary toxicity.
    • Physicians must be vigilant for lung toxicity in patients receiving mitomycin and vindesine.
    • Awareness of variable clinical manifestations is key for timely diagnosis and management.